AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)

CAPS Rating: 3 out of 5

Recs

0
Player Avatar line70day (< 20) Submitted: 1/21/2013 11:34:01 AM : Outperform Start Price: $8.94 ACRX Score: -9.19

up 30% after excellent results with drug sufentanil nonotab pca1yr change 81.31%

Featured Broker Partners


Advertisement